Company Valuation: VISEN Pharmaceuticals

Data adjusted to current consolidation scope
Fiscal Period: December 2025 2026 2027 2028
Market Cap 1 3,095 1,798 - -
Change - -41.91% - -
Enterprise Value (EV) 1 2,640 1,536 1,799 1,938
Change - -41.82% 17.11% 7.77%
P/E -12.1x -17.5x -29.4x -
PBR 4.22x 3.61x 4.43x 16.8x
PEG -0.5x 0.3x 0.7x -
Capitalization / Revenue 18,761x 26.5x 4.02x 2.09x
EV / Revenue 15,999x 22.7x 4.02x 2.25x
EV / EBITDA -12.1x -6.36x -10.7x -11.8x
EV / EBIT -12.7x -6.25x -10.5x -30.5x
EV / FCF - -11.1x -13.6x -31.1x
FCF Yield - -9.02% -7.34% -3.22%
Dividend per Share 2 - - - -
Rate of return - - - -
EPS 2 -2.44 -0.94 -0.56 -
Distribution rate - - - -
Net sales 1 0.165 67.73 447.4 860.8
EBITDA 1 -218 -241.4 -168.2 -164.1
EBIT 1 -208.6 -245.7 -170.5 -63.6
Net income 1 -253.4 -99 -58 -
Net Debt 1 -455.7 -262.3 0.4861 140.2
Reference price 2 29.47 16.49 16.49 16.49
Nbr of stocks (in thousands) 105,021 109,035 - -
Announcement Date 3/12/26 - - -
1CNY in Million2CNY
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-17.54x22.67x-6.36x-.--% 266M
32.25x5.76x17.3x1.02% 46.86B
-23.62x354.58x-21.66x-.--% 40.23B
48.91x4.94x31.87x-.--% 36.23B
25.32x2.8x12.1x-.--% 34.72B
27.42x8.04x20.17x0.41% 27.89B
34.31x5.61x25.58x-.--% 16.79B
22.12x1.95x8.48x1.19% 13.12B
23.43x1.87x11.34x-.--% 12.7B
Average 19.18x 45.36x 10.98x 0.29% 25.42B
Weighted average by Cap. 22.45x 66.36x 12.06x 0.33%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 2561 Stock
  4. Valuation VISEN Pharmaceuticals